Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
0.9431
+0.1007 (11.95%)
Nov 13, 2026, 4:00 PM EST - Market closed

Perspective Therapeutics Revenue

Perspective Therapeutics had revenue of $20.00K in the quarter ending September 30, 2026, a decrease of -90.43%. This brings the company's total for the last twelve months to $220.00K, down -79.53% year-over-year. In the year 2025, Perspective Therapeutics had annual revenue of $884.00K, down -39.20%. That makes Perspective Therapeutics the 45,403rd largest company in the world by revenue and 6,592nd in the United States.

Revenue (ttm)
$220.00K
Revenue Growth
-79.53%
P/S Ratio
517.67
Revenue / Employee
$1,325
Employees
166
Market Cap
113.89M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025884.00K-570.00K-39.20%
Dec 31, 20241.45M20.00K1.39%
Dec 31, 20231.43M--
Jun 30, 2022---
Jun 30, 202110.05M373.00K3.85%
Jun 30, 20209.68M2.37M32.35%
Jun 30, 20197.31M1.39M23.48%
Jun 30, 20185.92M1.16M24.41%
Jun 30, 20174.76M-8.00K-0.17%
Jun 30, 20164.77M163.00K3.54%
Jun 30, 20154.61M386.84K9.17%
Jun 30, 20144.22M-306.08K-6.76%
Jun 30, 20134.53M-545.86K-10.76%
Jun 30, 20125.07M-167.89K-3.20%
Jun 30, 20115.24M-47.11K-0.89%
Jun 30, 20105.29M-131.73K-2.43%
Jun 30, 20095.42M-1.74M-24.32%
Jun 30, 20087.16M1.42M24.76%
Jun 30, 20075.74M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Neuronetics159.76M
Outset Medical121.97M
Owlet114.41M
Pulmonx88.78M
Apyx Medical59.57M
TriSalus Life Sciences46.39M
MaxCyte34.37M
Nyxoah32.77M
Revenue Rankings